NeoGenomics, Inc. (NEO) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 374.24M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.35B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $374.24M | (m) | (m) | $1.35B | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $341.86M | (m) | (m) | $1.36B | (m) |
| 2024-12-31 | (m) | (m) | $200.78M | $340.33M | (m) | (m) | $1.64B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $538.20M | (m) | (m) | $1.68B | (m) |
| 2020-12-31 | (m) | (m) | $0.00 | (m) | (m) | $296.26M | $988.33M | (m) |
| 2020-09-30 | (m) | (m) | $0.00 | (m) | (m) | $283.61M | $959.43M | (m) |
| 2020-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $945.49M | (m) |
| 2019-12-31 | (m) | (m) | $5.00M | (m) | (m) | (m) | $709.51M | (m) |
| 2018-12-31 | (m) | (m) | $7.87M | $92.88M | (m) | (m) | $505.01M | (m) |
| 2017-12-31 | (m) | (m) | $3.75M | $91.13M | (m) | (m) | $343.34M | (m) |
| 2017-03-31 | (m) | (m) | $3.75M | $96.13M | (m) | (m) | $343.64M | (m) |
| 2016-12-31 | (m) | (m) | $3.75M | $91.95M | (m) | (m) | $337.12M | (m) |
| 2016-09-30 | (m) | (m) | $646.00K | $52.19M | (m) | (m) | $355.43M | (m) |
| 2016-06-30 | (m) | (m) | $646.00K | $52.24M | (m) | (m) | $351.56M | (m) |
| 2016-03-31 | (m) | (m) | $596.00K | $52.32M | (m) | (m) | $346.84M | (m) |
| 2015-12-31 | (m) | (m) | $550.00K | $52.25M | (m) | (m) | $367.95M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |